Market Research Logo

Biotechnology in China

Executive Summary
Market value
Market value forecast
Category segmentation
Geography segmentation
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Category segmentation
Geography segmentation
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Novo Nordisk A/S
Shanghai Kehua Bio-engineering Co., Ltd
Sinovac Biotech Ltd.
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine
List of Tables
Table 1: China biotechnology industry value: $ billion, 2012-16
Table 2: China biotechnology industry category segmentation: $ billion, 2016
Table 3: China biotechnology industry geography segmentation: $ billion, 2016
Table 4: China biotechnology industry value forecast: $ billion, 2016-21
Table 5: Novo Nordisk A/S: key facts
Table 6: Novo Nordisk A/S: key financials ($)
Table 7: Novo Nordisk A/S: key financials (DKK)
Table 8: Novo Nordisk A/S: key financial ratios
Table 9: Shanghai Kehua Bio-engineering Co., Ltd: key facts
Table 10: Shanghai Kehua Bio-engineering Co., Ltd: key financials ($)
Table 11: Shanghai Kehua Bio-engineering Co., Ltd: key financials (CNY)
Table 12: Shanghai Kehua Bio-engineering Co., Ltd: key financial ratios
Table 13: Sinovac Biotech Ltd.: key facts
Table 14: Sinovac Biotech Ltd.: key financials ($)
Table 15: Sinovac Biotech Ltd.: key financial ratios
Table 16: China size of population (million), 2012-16
Table 17: China gdp (constant 2005 prices, $ billion), 2012-16
Table 18: China gdp (current prices, $ billion), 2012-16
Table 19: China inflation, 2012-16
Table 20: China consumer price index (absolute), 2012-16
Table 21: China exchange rate, 2012-16
List of Figures
Figure 1: China biotechnology industry value: $ billion, 2012-16
Figure 2: China biotechnology industry category segmentation: % share, by value, 2016
Figure 3: China biotechnology industry geography segmentation: % share, by value, 2016
Figure 4: China biotechnology industry value forecast: $ billion, 2016-21
Figure 5: Forces driving competition in the biotechnology industry in China, 2016
Figure 6: Drivers of buyer power in the biotechnology industry in China, 2016
Figure 7: Drivers of supplier power in the biotechnology industry in China, 2016
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in China, 2016
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in China, 2016
Figure 10: Drivers of degree of rivalry in the biotechnology industry in China, 2016
Figure 11: Novo Nordisk A/S: revenues & profitability
Figure 12: Novo Nordisk A/S: assets & liabilities
Figure 13: Shanghai Kehua Bio-engineering Co., Ltd: revenues & profitability
Figure 14: Shanghai Kehua Bio-engineering Co., Ltd: assets & liabilities
Figure 15: Sinovac Biotech Ltd.: revenues & profitability
Figure 16: Sinovac Biotech Ltd.: assets & liabilities

Biotechnology in China

Summary

Biotechnology in China industry profile provides top-line qualitative and quantitative summary information including: market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.Synopsis

Essential resource for top-line data and analysis covering the China biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.Key Highlights

  • The biotechnology industry consists of the development, manufacturing, and industrying of products based on advanced biotechnology research.
  • The Chinese biotechnology industry had total revenues of $17.4bn in 2016, representing a compound annual growth rate (CAGR) of 8.4% between 2012 and 2016.
  • The medical/healthcare segment was the industry's most lucrative in 2016, with total revenues of $17.0bn, equivalent to 97.8% of the industry's overall value.
  • There is a growing medical/healthcare segment due to the aging population, which puts more pressure on this segment and requires the development of new drugs.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in China
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in China
  • Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the China biotechnology market with five year forecasts
Reasons to buy
  • What was the size of the China biotechnology market by value in 2016?
  • What will be the size of the China biotechnology market in 2021?
  • What factors are affecting the strength of competition in the China biotechnology market?
  • How has the market performed over the last five years?
  • What are the main segments that make up China's biotechnology market?


Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report

;